RISK FACTORS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA

被引：0
|
作者：
Baurmann, H. [1 ]
Collenbusch, F. [1 ]
Schmid, C. [2 ]
Finke, J. [3 ]
Stadler, M. [4 ]
Borubaeuser, M. [5 ]
Schleuning, M. [1 ]
Schwerdtfeger, R. [1 ]
机构：
[1] Deutsch Klin Diagnost, D-6200 Wiesbaden, Germany
[2] Univ Munich, Munich, Germany
[3] Univ Freiburg, Freiburg, Germany
[4] Leibniz Univ Hannover, Hannover, Germany
[5] Univ Dresden, Dresden, Germany
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2008年 / 14卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2007.12.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] Improving allogeneic stem cell transplantation in myelofibrosis
    Nico Gagelmann
    Nicolaus Kröger
    International Journal of Hematology, 2022, 115 : 619 - 625
  • [32] Improving allogeneic stem cell transplantation in myelofibrosis
    Gagelmann, Nico
    Kroeger, Nicolaus
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (05) : 619 - 625
  • [33] Allogeneic Stem Cell Transplantation for Myelofibrosis in 2012
    McLornan, Donal P.
    Mead, Adam J.
    Jackson, Graham
    Harrison, Claire N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (04) : 413 - 425
  • [34] Allogeneic stem cell transplantation as treatment for myelofibrosis
    S G Papageorgiou
    A Castleton
    A Bloor
    P D Kottaridis
    Bone Marrow Transplantation, 2006, 38 : 721 - 727
  • [35] Reduced-intensity allogeneic HSCT in patients with myeloid metaplasia with myelofibrosis
    Musso, M
    Porretto, F
    Crescimanno, A
    Polizzi, V
    Scalone, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S206 - S206
  • [36] Risk factors for elastic transformation in myelofibrosis with myeloid metaplasia (MMM).
    Barosi, G
    Quaglini, S
    Petti, C
    Grossi, A
    Pogliani, E
    Leoni, P
    Rotoli, B
    Finelli, C
    Foa, P
    Ambrosetti, A
    Rodeghiero, F
    Centra, A
    Guarnone, R
    Liberato, NL
    BLOOD, 1995, 86 (10) : 3147 - 3147
  • [37] Allogeneic hematopoietic stern-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia
    Rondelli, D
    Barosi, G
    Bacigalupo, A
    Prchal, JT
    Popat, U
    Alessandrino, EP
    Spivak, JL
    Smith, BD
    Klingemann, HG
    Fruchtman, S
    Hoffman, R
    BLOOD, 2005, 105 (10) : 4115 - 4119
  • [38] Primary myelofibrosis relapsed with duodenal myeloid sarcoma after allogeneic stem cell transplantation
    Lu, Ying
    Huang, Qin
    LEUKEMIA & LYMPHOMA, 2009, 50 (11) : 1879 - 1881
  • [39] Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia
    Devine, SM
    Hoffman, R
    Verma, A
    Shah, R
    Bradlow, BA
    Stock, W
    Maynard, V
    Jessop, E
    Peace, D
    Huml, M
    Thomason, D
    Chen, YH
    van Besien, K
    BLOOD, 2002, 99 (06) : 2255 - 2258
  • [40] Allogeneic blood cell transplantation following reduced intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.
    Devine, SM
    Verma, A
    Shah, R
    Bradlow, BA
    Maynard, V
    Jessop, E
    Peace, D
    Huml, M
    Thomason, D
    Chen, YH
    Hoffman, R
    BLOOD, 2001, 98 (11) : 626A - 626A
12345